We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 646

IP in depth: patentable biotechnology a comparative analysis of key markets
  • Fisher Adams Kelly
  • Australia, European Union, New Zealand, USA
  • March 31 2015

There is extraordinary complexity and optimization underlying even comparatively 'simple' organisms. These powerful biological products and processes


Tribunal accepts that medication errors will happen but disciplines nurse for failing to report
  • Buddle Findlay
  • New Zealand
  • September 23 2013

While working on a busy ward, a nurse accidentally administered the wrong medications to a patient without the appropriate checks. The nurse soon


Privacy & cybersecurity update, issue 3 - October, 2014
  • Jones Day
  • Australia, Brazil, Canada, Chile, Taiwan, USA, Italy, Japan, Mexico, Netherlands, New Zealand, Russia, China, European Union, France, Germany, Hong Kong, Ireland
  • October 15 2014

On August 1, the Federal Trade Commission ("FTC") issued a report on mobile shopping applications. In it, the FTC found that such apps often fail to


Isolated nucleic acids are patent eligible in Australia
  • Baldwins
  • Australia, New Zealand
  • June 25 2014

Last year, the Federal Court of Australia confirmed that isolated naturally occurring nucleic acid sequences are patent eligible subject matter. The


Suspension for misappropriation of medication by nurse
  • Buddle Findlay
  • New Zealand
  • December 13 2011

A nurse has been found guilty of professional misconduct for ordering prescription medication for residents at a rest home when she knew or ought to have known that the medication was not being administered to the residents, and for misappropriating codeine phosphate tablets for her own use


Intellectual Property Laws Amendment Act 2015 update on recent changes to Australia’s intellectual property legislation
  • Davies Collison Cave
  • Australia, New Zealand
  • April 15 2015

The Intellectual Property Laws Amendment Act 2015 (Cth) received Royal Assent on 25 February 2015. Although some changes under the Act came into


Patentability of kit-of-parts claims - the contrast between New Zealand and Australia
  • Henry Hughes IP
  • Australia, New Zealand
  • April 30 2014

In combination therapy patents, the invention lies in the discovery of a particular therapeutic benefit to taking two (or more) different


Nagoya Protocol enters into force on 12 October 2014
  • Henry Hughes IP
  • Australia, Global, New Zealand
  • August 7 2014

The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilisation, a supplementary


US Supreme Court rethinks the patentability of human genes
  • Baldwins
  • Australia, New Zealand, USA
  • July 12 2013

The United States Supreme Court has made a U-turn on the patentability of DNA. In AMP v Myriad, the Court held that "a naturally occurring DNA


Myriad vs. genetic diagnostic companies - round two
  • AJ Park
  • New Zealand
  • July 12 2013

As we reported yesterday, Myriad Genetics has already filed a lawsuit against Ambry Genetics alleging patent infringement of 10 different patents